| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |